Paket 10 vial5 stokHemat 17%Retatrutide 60 mg
Peptida riset tri-agonis GLP-1 / GIP / glukagon
Retatrutide tri-agonist research peptide, Australian-shipped. Lab-verified ≥99% purity.
Hanya untuk keperluan penelitian. Senyawa ini dijual secara ketat untuk penelitian in-vitro dan keperluan laboratorium, dan tidak dimaksudkan untuk konsumsi manusia atau penggunaan terapeutik. Dengan membeli, Anda menegaskan bahwa Anda adalah peneliti yang memenuhi syarat dan menyetujui penyangkalan lengkap kami.
Tersisa 5 paket
Peptida riset agonis tiga reseptor yang dikaji untuk efek gabungan pada jalur sinyal GLP-1, GIP, dan glukagon dalam aplikasi riset metabolik.
Retatrutide is a synthetic tri-agonist research peptide that activates the GLP-1, GIP, and glucagon receptors simultaneously. It is part of a new generation of incretin-receptor research compounds developed to study combined activation of multiple metabolic pathways. Quantum Labs supplies Retatrutide as a lyophilised powder for Australian research applications.
Retatrutide is studied alongside other incretin-receptor agonists — semaglutide (single-agonist GLP-1) and tirzepatide (dual-agonist GLP-1/GIP) — in pre-clinical and clinical research literature. The tri-agonist mechanism is the distinguishing feature that places it in its own research category. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mekanisme
Dikaji untuk agonisme simultan reseptor GLP-1, GIP, dan glukagon. Riset dikaitkan dengan penanda laju metabolisme, rasa kenyang, dan pengeluaran energi pada populasi studi.
Diverifikasi HPLC terhadap spesifikasi kemurnian ≥99%. Diuji secara independen oleh laboratorium pihak ketiga terakreditasi.
Retatrutide — pertanyaan yang sering diajukan
What is Retatrutide?
Retatrutide is a synthetic tri-agonist research peptide that simultaneously activates the GLP-1, GIP, and glucagon receptors. It is a newer-generation incretin-receptor research compound.
Is Retatrutide legal in Australia?
Retatrutide is not an approved therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Retatrutide for research use only — it is not a substitute for prescription weight-loss medication.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual-agonist activating GLP-1 and GIP receptors. Retatrutide is a tri-agonist activating GLP-1, GIP, and glucagon receptors. The added glucagon-receptor activity is the distinguishing pharmacological feature of Retatrutide.
What is the difference between Retatrutide and Mounjaro?
Mounjaro is the brand name for the approved prescription medicine tirzepatide. Retatrutide is a separate research peptide with an additional glucagon-receptor agonism. They are different molecules studied in parallel research literature. Quantum Labs does not supply prescription medicines.
What is the typical Retatrutide research dosage?
Published clinical research has used Retatrutide doses across a wide titration range. Research-protocol dosing varies by model. Human therapeutic dosing is not established. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
Panduan terkait Retatrutide
Peneliti juga menelusuri
Paket 10 vialHemat 22%MOTS-c
Serbuk liofilisasi10 mg · 2 strengths
Peptida metabolik turunan mitokondria
Dalam 2 stack
Paket 10 vialHemat 17%5-Amino-1MQ
Serbuk liofilisasi50 mg · 3 strengths
Senyawa riset inhibitor NNMT
Paket 10 vialHemat 15%L-Carnitine
Sterile solution10 ml × 600 mg/ml
Transporter asam lemak mitokondria
Dalam 1 stack